UB
BPMC

UMB Bank’s Blueprint Medicines BPMC Stock Holding History

UMB Bank’s Portfolio BPMC Stock Details BPMC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-135
Closed -$17.3K – 2159
2025
Q2 		$17.3K Buy
135
+8
+6% +$831 ﹤0.01% 1426
2025
Q1 		$11.2K Hold
127
– – ﹤0.01% 1510
2024
Q4 		$11.1K Sell
127
-16
-11% -$1.47K ﹤0.01% 1441
2024
Q3 		$13.2K Sell
143
-2
-1% -$199 ﹤0.01% 1386
2024
Q2 		$15.6K Sell
145
-13
-8% -$1.3K ﹤0.01% 1155
2024
Q1 		$15K Sell
158
-28
-15% -$2.4K ﹤0.01% 1177
2023
Q4 		$17.2K Hold
186
– – ﹤0.01% 1117
2023
Q3 		$9.34K Hold
186
– – ﹤0.01% 1307
2023
Q2 		$11.8K Sell
186
-115
-38% -$6.25K ﹤0.01% 1258
2023
Q1 		$13.5K Buy
301
+158
+110% +$7.12K ﹤0.01% 1205
2022
Q4 		$6K Hold
143
– – ﹤0.01% 1397
2022
Q3 		$9K Sell
143
-8
-5% -$514 ﹤0.01% 1333
2022
Q2 		$8K Hold
151
– – ﹤0.01% 1445
2022
Q1 		$10K Sell
151
-28
-16% -$2.01K ﹤0.01% 1477
2021
Q4 		$19K Buy
+179
New +$18.7K ﹤0.01% 1283

Other funds holding BPMC

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

UMB Bank's BPMC Position: Q3 2025 in Review

UMB Bank sold out of Blueprint Medicines (BPMC) in Q3 2025, closing a stake of 135 shares — an estimated $17.3K sold.

UMB Bank first reported a position in BPMC in Q4 2021 and held it in 15 quarters. The position peaked at $19K in Q4 2021. 5 funds tracked by Wall St. Rank hold BPMC as of Q3 2025.

  • UMB Bank reported no remaining Blueprint Medicines position as of Q3 2025 after selling out during the quarter.
  • UMB Bank sold 135 Blueprint Medicines shares in Q3 2025, an estimated $17.3K.
  • UMB Bank first reported a position in Blueprint Medicines in Q4 2021 and held it in 15 quarters.
  • UMB Bank's Blueprint Medicines position peaked at $19K in Q4 2021.
  • 5 funds tracked by Wall St. Rank held Blueprint Medicines as of Q3 2025.

Based on UMB Bank's 13F filing for Q3 2025, filed 4 Nov 2025.